PortalPublikationenInitial Treatment of Patients with Primary Breast Cancer: Ev...

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)

Standard

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017). / Untch, Michael; Huober, Jens; Jackisch, Christian; Schneeweiss, Andreas; Brucker, Sara Y; Dall, Peter; Denkert, Carsten; Fasching, Peter A; Fehm, Tanja; Gerber, Bernd; Janni, Wolfgang; Kühn, Thorsten; Lüftner, Diana; Möbus, Volker; Müller, Volkmar; Rody, Achim; Sinn, Peter; Thill, Marc; Thomssen, Christoph; Harbeck, Nadia; Liedtke, Cornelia.

in: GEBURTSH FRAUENHEILK, Jahrgang 77, Nr. 6, 06.2017, S. 633-644.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Untch, M, Huober, J, Jackisch, C, Schneeweiss, A, Brucker, SY, Dall, P, Denkert, C, Fasching, PA, Fehm, T, Gerber, B, Janni, W, Kühn, T, Lüftner, D, Möbus, V, Müller, V, Rody, A, Sinn, P, Thill, M, Thomssen, C, Harbeck, N & Liedtke, C 2017, 'Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)', GEBURTSH FRAUENHEILK, Jg. 77, Nr. 6, S. 633-644. https://doi.org/10.1055/s-0043-111601

APA

Untch, M., Huober, J., Jackisch, C., Schneeweiss, A., Brucker, S. Y., Dall, P., Denkert, C., Fasching, P. A., Fehm, T., Gerber, B., Janni, W., Kühn, T., Lüftner, D., Möbus, V., Müller, V., Rody, A., Sinn, P., Thill, M., Thomssen, C., ... Liedtke, C. (2017). Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017). GEBURTSH FRAUENHEILK, 77(6), 633-644. https://doi.org/10.1055/s-0043-111601

Vancouver

Untch M, Huober J, Jackisch C, Schneeweiss A, Brucker SY, Dall P et al. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017). GEBURTSH FRAUENHEILK. 2017 Jun;77(6):633-644. https://doi.org/10.1055/s-0043-111601

Bibtex

@article{04e9ca6c3bfa4b5f88c723b059941246,
title = "Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)",
abstract = "The St. Gallen International Consensus Conference on the treatment of patients with primary breast cancer has been held regularly (every second year in the last six years) for more than 30 years. This year, the findings of the International St. Gallen Consensus Panel and their implications for clinical practice were again discussed by a German working group of leading breast cancer specialists. Five of the breast cancer specialists from Germany were also members of this year's St. Gallen panel. A comparison between the St. Gallen recommendations and the annually updated treatment guidelines of the Gynecologic Oncology Group (AGO 2017) and the S3-guideline agreed upon in 2017 is useful. The recommendations of the St. Gallen panel represent an international cross-section of opinions of experts from different countries and different disciplines, while the S3-guideline and AGO guidelines are evidence-based. The motto of this year's 15th St. Gallen Conference was {"}Escalating and De-Escalating{"}. The rationale behind this concept was to promote more individualized treatment and thereby reduce overtreatment as well as undertreatment.",
keywords = "Journal Article",
author = "Michael Untch and Jens Huober and Christian Jackisch and Andreas Schneeweiss and Brucker, {Sara Y} and Peter Dall and Carsten Denkert and Fasching, {Peter A} and Tanja Fehm and Bernd Gerber and Wolfgang Janni and Thorsten K{\"u}hn and Diana L{\"u}ftner and Volker M{\"o}bus and Volkmar M{\"u}ller and Achim Rody and Peter Sinn and Marc Thill and Christoph Thomssen and Nadia Harbeck and Cornelia Liedtke",
year = "2017",
month = jun,
doi = "10.1055/s-0043-111601",
language = "English",
volume = "77",
pages = "633--644",
journal = "GEBURTSH FRAUENHEILK",
issn = "0016-5751",
publisher = "Georg Thieme Verlag KG",
number = "6",

}

RIS

TY - JOUR

T1 - Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)

AU - Untch, Michael

AU - Huober, Jens

AU - Jackisch, Christian

AU - Schneeweiss, Andreas

AU - Brucker, Sara Y

AU - Dall, Peter

AU - Denkert, Carsten

AU - Fasching, Peter A

AU - Fehm, Tanja

AU - Gerber, Bernd

AU - Janni, Wolfgang

AU - Kühn, Thorsten

AU - Lüftner, Diana

AU - Möbus, Volker

AU - Müller, Volkmar

AU - Rody, Achim

AU - Sinn, Peter

AU - Thill, Marc

AU - Thomssen, Christoph

AU - Harbeck, Nadia

AU - Liedtke, Cornelia

PY - 2017/6

Y1 - 2017/6

N2 - The St. Gallen International Consensus Conference on the treatment of patients with primary breast cancer has been held regularly (every second year in the last six years) for more than 30 years. This year, the findings of the International St. Gallen Consensus Panel and their implications for clinical practice were again discussed by a German working group of leading breast cancer specialists. Five of the breast cancer specialists from Germany were also members of this year's St. Gallen panel. A comparison between the St. Gallen recommendations and the annually updated treatment guidelines of the Gynecologic Oncology Group (AGO 2017) and the S3-guideline agreed upon in 2017 is useful. The recommendations of the St. Gallen panel represent an international cross-section of opinions of experts from different countries and different disciplines, while the S3-guideline and AGO guidelines are evidence-based. The motto of this year's 15th St. Gallen Conference was "Escalating and De-Escalating". The rationale behind this concept was to promote more individualized treatment and thereby reduce overtreatment as well as undertreatment.

AB - The St. Gallen International Consensus Conference on the treatment of patients with primary breast cancer has been held regularly (every second year in the last six years) for more than 30 years. This year, the findings of the International St. Gallen Consensus Panel and their implications for clinical practice were again discussed by a German working group of leading breast cancer specialists. Five of the breast cancer specialists from Germany were also members of this year's St. Gallen panel. A comparison between the St. Gallen recommendations and the annually updated treatment guidelines of the Gynecologic Oncology Group (AGO 2017) and the S3-guideline agreed upon in 2017 is useful. The recommendations of the St. Gallen panel represent an international cross-section of opinions of experts from different countries and different disciplines, while the S3-guideline and AGO guidelines are evidence-based. The motto of this year's 15th St. Gallen Conference was "Escalating and De-Escalating". The rationale behind this concept was to promote more individualized treatment and thereby reduce overtreatment as well as undertreatment.

KW - Journal Article

U2 - 10.1055/s-0043-111601

DO - 10.1055/s-0043-111601

M3 - SCORING: Journal article

C2 - 28769126

VL - 77

SP - 633

EP - 644

JO - GEBURTSH FRAUENHEILK

JF - GEBURTSH FRAUENHEILK

SN - 0016-5751

IS - 6

ER -